France· FR:68274328
MANNITOL B. BRAUN 10 POUR CENT, solution pour perfusion
A medicinal product containing mannitol, registered in France by B BRAUN MEDICAL.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MANNITOL
- Manufacturer
- B BRAUN MEDICAL
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009363706301 poche(s) (ECOFLAC) polyéthylène basse densité (PEBD) de 250 ml
- cip1334009363708691 poche(s) (ECOFLAC) polyéthylène basse densité (PEBD) de 500 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mannitol in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARDEAOSMOSOL MA 10%ARDEAPHARMA, a.s., Ševětín
- United KingdomBronchitol 40mg inhalation powder capsules with deviceChapper Healthcare
- NorwayAridolPharmaxis
- United StatesMannitolHospira, Inc.
- GermanyAridolPharmaxis Europe Limited
- SwitzerlandMannitol 20 % Braun, InfusionslösungB. Braun Medical AG
- CanadaARIDOLPHARMAXIS EUROPE LIMITED
- SpainBRONCHITOL 40 MG POLVO PARA INHALACION, CAPSULAS DURASPharmaxis Europe Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Mannit Fresenius
- Belgium · Mannitol Viaflo Baxter, Mannitol, Viaflo Baxter
- Bulgaria · Манитол Б. Браун, Манитол Бакстер
- Cyprus · Mannitol Demo, Mannitol Βιοσερ
- Czechia · Ardeaosmosol Ma, Manitol Viaflo Baxter
- Germany · Aridol, Mannit-Lösung Serag
- Denmark · Mannitol Fresenius Kabi, Osmohale
- Estonia · Mannitol Fresenius
- Spain · Manitol Mein, Osmofundina
- Finland · Aridol, Mannitol Braun
- United Kingdom (Northern Ireland) · Mannitol Baxter Healthcare, Osmohale
- Greece · Mannitol Bradex, Mannitol Cooper
- Croatia · Manitol Hztm
- Hungary · Mannisol A, Mannisol B
- Ireland · Mannitol Baxter Holding, Osmohale
- Iceland · Bronchitol, Mannitol Viaflo Baxter
- Italy · Mannitolo Bioindustria L.I.M, Mannitolo Bioindustria L.I.M.
- Liechtenstein · Bronchitol
- Lithuania · Mannitol Fresenius
- Luxembourg · Mannitol Viaflo, Mannitol Viaflo Baxter
- Latvia · Mannitol Fresenius
- Malta · Mannitol Baxter Holding, Mannitol Monico
- Netherlands · Mannitol Baxter, Osmohale
- Norway · Aridol, Bronchitol
- Poland · Mannitol Baxter, Mannitol Fresenius
- Portugal · Manitol Braun, Manitol Labesfal
- Romania · Manitol Infomed Fluids, Mannitol Vioser
- Sweden · Aridol, Mannitol Fresenius Kabi
- Slovenia · Manitol Hztm
- Slovakia · Infusio Mannitoli, Mannitol Bieffe
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/61db935f-d313-4c86-82a6-262f83561ca2 GET /v1/drugs/61db935f-d313-4c86-82a6-262f83561ca2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68274328",
"date_amm": "1998-03-04",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MANNITOL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about mannitol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.